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INTRODUCTION
Potassium channels in vascular smooth muscle
plays an important role in controlling vascular tone.
Of these, ATP-sensitive K (KATP) channels and Ca2+-
activated K (KCa) channels are important because
they are abundant on cell membranes and effectively
control membrane potential as well as vascular tone.
We have reported that ginsenosides increase nitric
oxide (NO) production (1), and NO activates both
KCa (2) and KATP (3) channels. However, precise
mechanism of action has not been clarified. Recently,
some phytochemicals such as epigallocatechin-3-
gallate have been reported to increase NO produc-
tion and dilate arteries through the PI3K/Akt and
endothelial NO synthase (eNOS) pathways (4). In
addition, this compound acts through membrane
estrogen receptor (ER). Interestingly, the chemical
structures of estradiol and some phytochemicals,
especially phytoestrogens like ginsenosides, are simi-
lar to some degree. Medically, ginsenosides have
been to protect against cardiac ischemia, a major
cause of death in the West. In this study, we tested
the effect of ginsenosides Re on K channels of vas-
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cular smooth muscle cells and clarified their intra-
cellular mechanism and compared to those of in-
sulin.
METHODS
Cell cultures
Embryonic rat thoracic aortic smooth muscle cells
from DB1X rat (A10 cells) were obtained from Ameri-
can Type Culture Collection (ATCC, Manassas, VA).
They were cultured at 37in a humidified atmos-
phere with 95% air and 5% CO2 by Dulbecco’s modi-
fied Eagle’s medium (DMEM, Sigma, St. Louis, MO)
containing 0.5 mg/mL gentamicin (Sigma), and
10% fetal bovine serum or calf serum (Invitrogen,
Carlsbad, CA), respectively. The effects of a phy-
toestrogen, ginsenoside Re (Sigma Chemical Co.
St Louis, MO), on K channels were studied using
sub-confluent A10 cells cultured on cover slips. Gin-
senoside Re-induced phosphorylation of Akt was
measured by western blotting.
Patch-clamp experiments
Single KCa channel activities were measured by
using the cell-attached patch-clamp recordings. A10
cells, subcultured on glass cover-slips, were placed
in the experimental chamber filled with the buffered
solution, containing (in mmol/L) KCl 140, MgCl2 1,
CaCl2 0.1, D-glucose 5.5, HEPES 10, pH7.2. The
buffered solution into the pipettes was containing
(in mmol/L) KCl 140, D-glucose 5.5, HEPES 10,
pH 7.2. The patch pipettes were made from the
soft-glass capillaries (DRUMMOND SCIENTIFIC,
Broomall, PA) by using an electrode puller (PP-830,
Narishige, Tokyo, Japan). The resistance of the pi-
pettes filled with the buffered solution was 7-10 MΩ.
All drugs were added into the dishes. Inside of the
pipette was voltage-clamped at +50 mV. All patch-
clamp experiments were performed at 37.
The currents of patched cell membrane were re-
corded with a patch clamp amplifier (L/M-EPC7,
List-Medical, Darmstadt, Germany) and converted
into digital files by using DigiData 1200 (Axon In-
struments, Foster, CA). To remove the noises, we
used a low-pass filter of 1 kHz. pClamp version 6
software (Axon Instruments) was used for record-
ing the data and BIO-PATCH Ver.3.42 software
(BIO-LOGIC, Claix, France) was used for analysis
of the recording data. The open probability (NPo)
of the ion channel was determined from current am-
plitude histograms and was calculated as follows :
NPo=Σ(nPn)
where N means the number of channels in the
patch and Pn means the integrated channel opening.
The NPo of the KATP channels were determined
from recordings during more than 120 s.
Cell preparation and Western blotting analysis
After preincubation in the HBS for 30 min, the
cells were treated with the drugs. Before stimula-
tion with 100 nmol/L insulin, the cells were pre-
treated with or without 100 nmol/L wortmannin or
100 nmol/L L-NAME for 10 min. The cells were
lysed by cold cell lysis buffer containing (in mmol/L)
NaCl 140, Tris-HCl 20, MgCl2 1, CaCl2 1, dithio-
threitol 1, sodium vanadate 0.5, sodium pyrophos-
phate 20, phenylmethanesulfonyl fluoride 0.02, 10%
glycerol (v/v), 1% Nonidet P40 (v/v). Total cell
membrane lysates were obtained as described (5).
The cell lysates were electrophoresed in a sodium
dodecyl sulfate (SDS) - polyacrylamide gel and trans-
ferred to the nitrocellulose membrane (Schleicher
& Schnell Bioscience, Dassel, Germany). The mem-
branes were incubated with the specific antibodies
respectively as primary antibodies. Primary antibod-
ies were detected with the appropriate horseradish
peroxidase-conjugated secondary antibodies and im-
munoreactive bands were visualized using a enhanced
chemi-luminescence substrate. We captured chemi-
luminescence images by using LAS3000-UVmini
(Fujifilm, Tokyo, Japan). Blots were stripped by in-
cubation in stripping buffer containing (in mmol/L)
Tris-HCl 62.5, and 2-mercaptoethanol 100, 2% SDS,
pH 6.8, at 50for 40 min for a second round im-
munoblotting.
Statistical analysis
The statistical analysis of differences was esti-
mated by the Student’s t-test for unpaired samples.
A value of P0.05 was considered statistically sig-
nificant.
RESULTS
Ginsenoside Re activates KCa channels through eNOS
Ginsenoside Re is reported to enhance potassium
currents in cardiac myocytes in a NO-dependent man-
ner (5). We found that in A10 aortic smooth muscle
cells, ginsenoside Re also activated KCa channels
dose-dependently with an EC50 of 4.10.3 μM (n=
15). In the presence of 100nM Nω-nitro-L-arginine
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(L-NAMA), a nitric oxide synthase (NOS) inhibitor,
ginsenosides Re failed to activate KCa channels, sug-
gesting the involvement of NO in this pathway. Treat-
ment with 1 μM L-NIO, an inhibitor of eNOS, inhib-
ited the KCa channel-opening effect of ginsenoside Re,
whereas 3 μM SMTC, an inhibitor of nNOS, did not,
indicating that this ginsenoside activates KCa chan-
nels via eNOS.
Ginsenoside Re Activates eNOS via PI3-Kinase/Akt
Pathway
Recently, eNOS has been found to be activated
via the PI3 kinase pathway by epigallocatechin, an-
other phytochemical (4). We observed that SH-6
(10 μM), an Akt inhibitor, and wortmannin, a PI3-
kinase inhibitor, completely blocked activation of KCa
channels by ginsenoside Re, indicating that the gin-
senoside Re activates eNOS via a c-Src/PI3-kinase/
Akt-dependent mechanism.
Phosphorylation of Akt at Ser473 occurs when Akt
is activated via a PI3-kinase-dependent pathway. We
confirmed that ginsenoside Re induced phosphoryla-
tion of Akt in A10 vascular smooth muscle cells in a
concentration-dependent manner. This increase in
phosphorylation was inhibited by wortmannin and
SH-6. These data further confirm that ginsenoside Re
activates Akt via the PI3K pathway.
In addition, the ginsenoside Re-induced eNOS ac-
tivation and KCa activation were blocked by 10 μM ICI
182,780, an inhibitor of membrane ER-α, suggest-
ing that eNOS activation occurs via a non-genomic
pathway of ER-α, in which c-Src, phosphoinositide
3-kinase, Akt, and eNOS are sequentially activated.
DISCUSSION
The present study provides convincing evidence
to clarify a cadioprotective mechanism of ginsenoside
Re in the cardiovascular system. We found that this
phytochemical releases NO via a nongenomic path-
way of sex steroid receptors resulting in KCa channel
activation in vascular smooth muscle cells.
In our previous study, we found that KCa channels
are controlled by various vasoactive substances, such
as NO, endothelin, and angiotensin II. Using rabbit
coronary artery, we found that K channels are very
important in control of vascular tone and blocking
them produces severe vasospasm (6, 7). Our pre-
sent study indicates that ginsenoside Re activates
the nongenomic pathway of sex steroid receptors
to activate eNOS and release NO. Ginsenoside Re-
induced KCa activation was blocked by inhibitors of
c-Src, PI3-kinase, Akt, and eNOS, which are key sig-
nal molecules of the nongenomic pathway of sex ster-
oid receptors, in which insulin also shares.
Hormone replacement therapy has been widely
used in postmenopausal women for preventing car-
diovascular events, osteoporosis, and other problems.
There are, however, accompanying adverse effects :
increased risk of estrogen-sensitive cancers (breast
cancer and ovarian cancer). These adverse effects
are considered to be mediated by genomic action of
estrogen. Therefore, drugs which only act through
nongenomic ER pathways are expected to avoid
these problems. Ginsenoside Re seems to be a spe-
cific agonist for the nongenomic pathway of sex ster-
oid receptors. In our previous studies, we found that
ginsenoside Re does not activate the genomic path-
way of sex steroid hormones, as it fails to recruit
coactivators upon binding of ginsenoside to the sex
hormone receptors (5). It also failed to promote
growth of the cultured breast cancer cell line MCF-7
(5). Thus, ginsenoside is a naturally harvested,
mechanism-specific agonist of sex steroid receptors.
We expect that Panax ginseng has been successfully
prescribed for health problems associated with the
postmenopausal periods.
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